MabVax Therapeutics Holdings, Inc.
(Other OTC/NBB : MBVX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
ARRYArray BioPharma Inc.
0.10%46.478.1%$739.31m
AMGNAmgen Inc.
0.40%176.831.3%$505.63m
CELGCelgene Corporation
0.05%91.811.3%$444.44m
GILDGilead Sciences, Inc.
-1.46%67.080.9%$405.49m
BIIBBiogen Inc.
-0.16%233.241.3%$387.04m
ILMNIllumina, Inc.
0.13%302.673.5%$336.20m
REGNRegeneron Pharmaceuticals, Inc.
0.02%298.272.6%$278.22m
SRPTSarepta Therapeutics, Inc.
-2.48%153.0214.7%$203.69m
ALXNAlexion Pharmaceuticals, Inc.
0.82%124.052.0%$199.78m
VRTXVertex Pharmaceuticals Incorporated
0.37%177.021.9%$188.18m
EXASExact Sciences Corporation
-0.35%115.7824.1%$139.99m
AAgilent Technologies, Inc.
-1.05%69.811.6%$133.85m
INCYIncyte Corporation
-1.36%80.282.5%$114.51m
BLUEBluebird Bio, Inc.
-1.38%133.8814.3%$97.84m
BMRNBioMarin Pharmaceutical Inc.
-1.67%82.594.3%$87.87m

Company Profile

MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA.